Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Laura Brege
AddedMar 31, 2024
UpdatedMay 31, 2026
Laura Brege

Laura Brege

Board Member, Mirum Pharmaceuticals

CrunchbaseLinkedIn

Laura Brege's Career

Mirum Pharmaceuticals
Mirum Pharmaceuticals

Foster City, CA, US

Board Member· Board
Dynavax Technologies
Dynavax Technologies

Berkeley, CA, US

Board Member· Board
Nodality
Nodality

South San Francisco, CA, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Laura Brege's Career

Mirum Pharmaceuticals
Mirum Pharmaceuticals
Public$497M1962018Foster City, CA, US
Board Member· Board

Leadership at Mirum Pharmaceuticals

Mike GreyMike GreyBoard Member
Patrick HeronPatrick HeronBoard Member
Ed MathersEd MathersBoard Member
Tiba AynechiTiba AynechiBoard Member
Laurent FischerLaurent FischerBoard Member
Niall O'DonnellNiall O'DonnellBoard Member

Similar to Mirum Pharmaceuticals

Intercept PharmaceuticalsIntercept PharmaceuticalsNew York City, NY, USPharmaceuticalsest. 2002Intercept PharmaceuticalsNew York City, NY, US · est. 2002

Intercept Pharmaceuticals: An American biopharma firm specializing in synthetic bile acid analogs for chronic liver diseases.

Public · $970M341
Mirata PharmaceuticalsMirata PharmaceuticalsPlymouth Meeting, PA, USPain Relief, Pharmaceuticalsest. 2017Mirata PharmaceuticalsPlymouth Meeting, PA, US · est. 2017

Mirata Pharmaceuticals: Innovating powerful, opioid-based pain relief solutions for patients and physicians.

Series A · $11M5
Catalyst PharmaceuticalsCatalyst PharmaceuticalsCoral Gables, FL, USPharmaceuticals, Therapiesest. 2002Catalyst PharmaceuticalsCoral Gables, FL, US · est. 2002

Catalyst Pharmaceuticals: A US-based biopharmaceutical firm developing therapies for debilitating diseases.

Public · $273.9M76
Bayer PharmaceuticalsBayer PharmaceuticalsBerlin, Berlin, DEDrugs, Pharmaceuticalsest. 2003Bayer PharmaceuticalsBerlin, Berlin, DE · est. 2003

Bayer Pharmaceuticals: A global enterprise specializing in biochemical research and drug manufacturing since 2008.

Public10k
Dynavax Technologies
Dynavax Technologies
Public$1.4B3511996Berkeley, CA, US
Board Member· Board

Leadership at Dynavax Technologies

Brent MacGregorBrent MacGregorBoard Member
Julie EastlandJulie EastlandBoard Member
Elaine SunElaine SunBoard Member
Dennis CarsonDennis CarsonFounder
Ryan SpencerRyan SpencerCEO
Scott MyersScott MyersBoard Member
Nodality
Nodality
Series B$62M752003South San Francisco, CA, US
CEO· C-Suite · Management

Leadership at Nodality

Garry NolanGarry NolanBoard Member
Michael GoldbergMichael GoldbergBoard Member
Omar PerezOmar PerezFounder
Greg CritchfieldGreg CritchfieldBoard Member
David SingerDavid SingerBoard Member
Andrew R. AllenAndrew R. AllenBoard Member

Similar to Nodality

NormunityNormunityWest Haven, CT, USCancer Treatmentsest. 2021NormunityWest Haven, CT, US · est. 2021

Normunity: A biotech firm innovating precision immuno-oncology medicines to boost body's cancer immunity.

Series A · $65M15
Nuon TherapeuticsNuon TherapeuticsSan Mateo, CA, USTherapiesest. 2002Nuon TherapeuticsSan Mateo, CA, US · est. 2002

Nuon Therapeutics: A US-based biotech firm innovating therapies for autoimmune and inflammatory diseases.

Series A · $48M75
NantkwestNantkwestCulver City, CA, USCancer Treatment, Immunotherapyest. 2014NantkwestCulver City, CA, US · est. 2014

ImmunityBio, Inc.: A US-based biotech firm specializing in immunotherapy for cancer and infectious diseases.

Public · $103.5M51
NantBioNantBioCulver City, CA, USPharmaceuticalsNantBioCulver City, CA, US

NantBioscience: LA-based developer of targeted pharmaceuticals for cancer treatment.

Late Stage Private · $180.1M75

Laura Brege's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailTakashi MitachiTakashi MitachiBoard Member · RakutenYuzo HashiyaYuzo HashiyaBoard Member · Rakuten

People Similar to Laura Brege

Carol AnelliCarol AnelliBoard Member · The Ohio State UniversityCasey HoyCasey HoyBoard Member · The Ohio State UniversityMohamed NawwarMohamed NawwarBoard Member · The Ohio State UniversityLaxmi MehtaLaxmi MehtaBoard Member · The Ohio State UniversityDale BaurDale BaurBoard Member · Case Western Reserve UniversityDavid A WolfortDavid A WolfortBoard Member · Olympic Steel